v3.24.0.1
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Cash and cash equivalents $ 221,684 $ 264,600
Non-Agency RMBS, at fair value (net of allowance for credit losses of $19 million and $7 million, respectively) 1,043,806 1,147,481
Agency MBS, at fair value 102,484 430,944
Loans held for investment, at fair value 11,397,046 11,359,236
Accrued interest receivable 76,960 61,768
Other assets 87,018 133,866
Derivatives, at fair value 0 4,096
Total assets [1] 12,928,998 13,401,991
Liabilities:    
Secured financing agreements ($3.6 billion and $4.7 billion pledged as collateral, respectively, and includes $350 million and $374 million at fair value, respectively) 2,432,115 3,434,765
Securitized debt, collateralized by Non-Agency RMBS ($249 million and $276 million pledged as collateral, respectively) 75,012 78,542
Securitized debt at fair value, collateralized by Loans held for investment ($10.7 billion and $10.0 billion pledged as collateral, respectively) 7,601,881 7,100,742
Payable for investments purchased 158,892 9,282
Accrued interest payable 38,272 30,696
Dividends payable 54,552 64,545
Accounts payable and other liabilities 9,355 16,616
Total liabilities [1] 10,370,079 10,735,188
Commitments and Contingencies (See Note 15)
Stockholders' Equity:    
Common stock: par value $0.01 per share; 500,000,000 shares authorized, 232,190,087 and 187,226,081 shares issued and outstanding, respectively 2,414 2,318
Additional paid-in-capital 4,368,520 4,318,388
Accumulated other comprehensive income 185,668 229,345
Cumulative earnings 4,165,046 4,038,942
Cumulative distributions to stockholders (6,163,101) (5,922,562)
Total stockholders' equity 2,558,919 2,666,803
Total liabilities and stockholders' equity 12,928,998 13,401,991
Variable Interest Entities, Primary Beneficiary    
Non-Agency RMBS, at fair value (net of allowance for credit losses of $19 million and $7 million, respectively) 248,993 276,030
Loans held for investment, at fair value 10,184,538 9,855,390
Accrued interest receivable 52,712 47,553
Other assets 15,597 20,293
Total assets 10,501,840 10,199,266
Liabilities:    
Securitized debt, collateralized by Non-Agency RMBS ($249 million and $276 million pledged as collateral, respectively) 75,012 78,542
Securitized debt at fair value, collateralized by Loans held for investment ($10.7 billion and $10.0 billion pledged as collateral, respectively) 7,248,768 6,673,917
Accrued interest payable 23,310 17,427
Accounts payable and other liabilities 2,019 2,239
Total liabilities 7,349,109 6,772,125
Series A Preferred Stock    
Stockholders' Equity:    
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: 58 58
Series B Preferred Stock    
Stockholders' Equity:    
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: 130 130
Series C Preferred Stock    
Stockholders' Equity:    
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: 104 104
Series D Preferred Stock    
Stockholders' Equity:    
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized: $ 80 $ 80
[1] The Company's consolidated statements of financial condition include assets of consolidated variable interest entities, or VIEs, that can only be used to settle obligations and liabilities of the VIE for which creditors do not have recourse to the primary beneficiary (Chimera Investment Corporation). As of December 31, 2023, and December 31, 2022, total assets of consolidated VIEs were $10,501,840 and $10,199,266, respectively, and total liabilities of consolidated VIEs were $7,349,109 and $6,772,125, respectively. See Note 8 for further discussion.

Source

PDF HTML
ZIP XBRL